In 1999, a group of dedicated individuals and organizations sought to put an end to the heavy burden of malaria. They established a public–private partnership, Medicines for Malaria Venture, endowing it with $4 million in seed finance to research and develop at least one antimalarial within 10 years.
20 years later, MMV has far exceeded these goals. With our partners, we have brought forward 12 new antimalarials, that have saved an estimated 1.9 million lives. We have a built robust pipeline of 65 antimalarial drug projects, a network of over 400 research and policy partners, and raised over a billion dollars to fund the R&D of new, affordable and effective antimalarials and ensure their equitable access and availability.
Today, with over 90 dedicated members of staff and 17 committed public and private sector donors, we are now seen as a leading product development partnership in the field of malaria drug development. And we continue to work with our partners towards our ultimate goal of defeating malaria together.
Participation in MMV's 20th anniversary event is by invitation. As we count down to MMV@20, each month we will add a new feature below and take a closer look at our progress over the past 20 years.